{"id":"W2062448901","doi":"10.1185/03007995.2014.944973","title":"Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Nilotinib; Imatinib; Internal medicine; Adverse effect; Incidence (geometry); Imatinib mesylate; Quality of life (healthcare); Chronic myelogenous leukemia; Philadelphia chromosome; Bosutinib; Tyrosine-kinase inhibitor; Myeloid leukemia; Gastroenterology; Leukemia; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002146663,0.0001764713,0.000450384,0.0002866581,0.0001531775,0.0004485905,0.0001512493,0.000215735,0.001160325],"category_scores_gemma":[0.004994089,0.00007250842,0.0007780271,0.0004644295,0.0001400608,0.000325367,0.0003184853,0.0004562202,0.00008282444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002141185,"about_ca_system_score_gemma":0.0002127279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005374408,"about_ca_topic_score_gemma":0.00134129,"domain_scores_codex":[0.9987497,0.0006913634,0.0001522307,0.0001042075,0.0001941653,0.0001082621],"domain_scores_gemma":[0.995503,0.001614277,0.002288539,0.00008512381,0.0002170599,0.0002920913],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001321572,0.000083976,0.9918356,0.00006205327,0.0002808029,0.00003329007,0.00001792733,0.0002464151,0.0001673959,0.000009998456,0.00009253011,0.005848376],"study_design_scores_gemma":[0.00006267249,0.0007254094,0.9982789,0.00001139895,0.0001344184,0.0001055382,0.00002539462,0.0004317677,0.00008936896,0.00001499262,0.0001176137,0.000002636218],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986106,0.0007302117,0.00008640019,0.00005863858,0.000004853714,0.00001328372,0.000293964,0.000001603388,0.0002003372],"genre_scores_gemma":[0.9994277,0.00009114899,0.00006245102,0.00002734582,0.000006715975,0.000009050398,0.0003278003,4.252945e-7,0.00004731698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002146663,"threshold_uncertainty_score":0.01135278,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09152452362728754,"score_gpt":0.4554350368855942,"score_spread":0.3639105132583066,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}